Omega Healthcare Investors Hits New 52-Week High at $48.11

Omega Healthcare Investors, Inc., a small-cap player in the realty sector, has reached a significant milestone by hitting a new 52-week high of USD 48.11 on February 26, 2026. This achievement underscores the company's strong performance over the past year, with a remarkable return of 50.99%, significantly outpacing the S&P 500's 12.95% return during the same period. The company boasts a market capitalization of USD 13,765 million and maintains a price-to-earnings (P/E) ratio of 25.00. With a dividend yield of 4.77%, Omega Healthcare Investors has demonstrated a commitment to returning value to its shareholders. The stock's price-to-book ratio stands at 2.66, indicating a premium valuation compared to its peers. Financially, Omega Healthcare has shown resilience, with operating cash flow reaching a high of USD 836.31 million and a return on equity (ROE) of 11.47%. The company has consistently reported positive results for the last four consecutive quarters, reflecting its operational strength. As it continues to navigate the realty landscape, Omega Healthcare's recent performance highlights its position within the market.